Whatever specific shape work takes in the near and distant future, it’s likely the COVID-19 era will be looked back upon as a before-and-after dividing line.

A therapeutic oncology company has been cleared to market a cancer treatment that that turns a tumor’s own biology into a self-signaling target for radiation therapy.

Instagram is a fairly close second, Facebook a fighting third, Twitter a respectable fourth and LinkedIn a visible fifth.

Clarius Mobile Health of Vancouver, B.C., has won FDA approval to market an AI model that works with the company’s handheld point-of-care ultrasound devices to identify and measure tendons of the foot, ankle and knee.

The human author reviewing the article wrote about the benefits and inherent risks of utilizing AI in a medical publication setting, concluding that, overall, it could be “a powerful tool” used in the future of medical publishing—when used with caution.

The plan, if finalized, increases payments for MA plans by 2.09%, or 1.03% after adjusting for star rating changes.

A new study published in JACC: Heart Failure offers more evidence that a patient's feelings can strongly influence their risk of poor cardiovascular health.